CDNA CareDx, Inc.
8-K Current Report
Filed: February 24, 2026
Health Care
Services-Medical LaboratoriesCareDx, Inc. (CDNA) 8-K current report filed with SEC EDGAR on February 24, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items3 items
- Item 2.02: Results of Operations and Financial Condition
- Item 5.02: Departure/Election of Directors or Officers
- Item 7.01: Regulation FD Disclosure
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q4 2025 earnings results announced Feb 24, 2026 — full financials in Exhibit 99.1
- • Period covered: quarter ended December 31, 2025
Item 5.02 · Departure/Election of Directors or Officers
- • CFO Nathan Smith resigned effective Feb 25, 2026 for personal reasons — no disagreement over financials or disclosures
- • COO Keith Kennedy immediately promoted to dual CFO/COO role effective Feb 26, 2026 — internal succession limits leadership disruption
Item 7.01 · Regulation FD Disclosure
- • Updated corporate presentation posted to CareDx website, current as of Feb 24, 2026
- • Reg FD disclosure ensures all investors receive material non-public information simultaneously — presentation may contain strategic or financial updates worth reviewing directly
Other CareDx, Inc. 8-K Filings
Get deeper insights on CareDx, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.